Resveratrol Increases Anti-Proliferative Activity of Bestatin Through Downregulating P-Glycoprotein Expression Via Inhibiting PI3K/Akt/mTOR Pathway in K562/ADR Cells

Journal of Cellular Biochemistry

Volumn 117, Issue 5, 2016, Pages 1233-1239

  Wang, Li ^a   Wang, Changyuan ^a   Jia, Yongming ^a   Liu, Zhihao ^a   Shu, Xiaohong ^a   Liu, Kexin ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

BESTATIN; CASPASE 3; P GLYCOPROTEIN; PI3K AKT mTOR; RESVERATROL

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; BESTATIN; CASPASE 3; CASPASE 8; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN 1; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; RESVERATROL; RHODAMINE 123; STRESS ACTIVATED PROTEIN KINASE; ANTINEOPLASTIC AGENT; CASPASE; DOXORUBICIN; LEUCINE; MTOR PROTEIN, HUMAN; STILBENE DERIVATIVE; TARGET OF RAPAMYCIN KINASE;

ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IC50; K562 CELL LINE; MTT ASSAY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; WESTERN BLOTTING; ANALOGS AND DERIVATIVES; CELL PROLIFERATION; CELL SURVIVAL; DRUG EFFECTS; DRUG POTENTIATION; DRUG RESISTANCE; ERYTHROLEUKEMIA; GENETICS; K-562 CELL LINE; METABOLISM; PATHOLOGY; PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; CASPASES; CELL PROLIFERATION; CELL SURVIVAL; DOWN-REGULATION; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; DRUG SYNERGISM; HUMANS; K562 CELLS; LEUCINE; LEUKEMIA, ERYTHROBLASTIC, ACUTE; P-GLYCOPROTEIN; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STILBENES; TOR SERINE-THREONINE KINASES;

EID: 84960171680     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.25407     Document Type: Article

References (29)

1. Aggarwal BB, Bhardwaj A, Aggarwal RS, Seeram NP, Shishodia S, Takada Y,. 2004. Role of resveratrol in prevention and therapy of cancer: Preclinical and clinical studies. Anticancer Res 24: 2783-2840.
2. Basson MD,. 2008. An intracellular signal pathway that regulates cancer cell adhesion in response to extracellular forces. Cancer Res 68: 2-4.
3. Brognard J, Clark AS, Ni Y, Dennis PA,. 2001. Akt/protein kinase B is constitutively active in non-small cell lung cancer cells and promotes cellular survival and resistance to chemotherapy and radiation. Cancer Res 61: 3986-3997.
4. Chen T, Wang C, Liu Q, Meng Q, Sun H, Huo X, Sun P, Peng J, Liu Z, Yang X, Liu K,. 2015. Dasatinib reverses the multidrug resistance of breast cancer MCF-7 cells to doxorubicin by downregulating P-gp expression via inhibiting the activation of ERK signaling pathway. Cancer Biol Ther 16: 106-114.
5. Chiarini F, Del Sole M, Mongiorgi S, Gaboardi GC, Cappellini A, Mantovani I, Follo MY, McCubrey JA, Martelli AM,. 2008. The novel Akt inhibitor, perifosine, induces caspase-dependent apoptosis and downregulates P-glycoprotein expression in multidrug-resistant human T-acute leukemia cells by a JNK-dependent mechanism. Leukemia 22: 1106-1116.
6. da Graça Rocha G, Simões M, Oliveira RR, Kaplan MAC, Gattass CR,. 2012. 3β-acetyl tormentic acid induces apoptosis of resistant leukemia cells independently of P-gp/ABCB1 activity or expression. Invest New Drugs 30: 105-113.
7. De Luca A, Maiello MR, D'Alessio A, Pergameno M, Normanno N,. 2012. The RAS/RAF/MEK/ERK and the PI3K/AKT signalling pathways: Role in cancer pathogenesis and implications for therapeutic approaches. Expert Opin Ther Targets 16 (Suppl 2): S17-S27.
8. Fulda S, Debatin K-M,. 2004. Sensitization for tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by the chemopreventive agent resveratrol. Cancer Res 64: 337-346.
9. Fulda S, Debatin K-M,. 2006. Resveratrol modulation of signal transduction in apoptosis and cell survival: A mini-review. Cancer Detect Prev 30: 217-223.
10. Gupta SC, Kannappan R, Reuter S, Kim JH, Aggarwal BB,. 2011. Chemosensitization of tumors by resveratrol. Ann NY Acad Sci 1215: 150-160.
11. Han Z, Hong L, Han Y, Wu K, Han S, Shen H, Li C, Yao L, Qiao T, Fan D,. 2007. Phospho Akt mediates multidrug resistance of gastric cancer cells through regulation of P-gp, Bcl-2 and Bax. J Exp Clin Cancer Res 26: 261-268.
12. Huang F, Wu X-N, Chen J, Wang W-X, Lu ZF,. 2014. Resveratrol reverses multidrug resistance in human breast cancer doxorubicin-resistant cells. Exp Ther Med 7: 1611-1616.
13. Huo X, Liu Q, Wang C, Meng Q, Sun H, Peng J, Ma X, Liu K,. 2013. Enhancement effect of P-gp inhibitors on the intestinal absorption and antiproliferative activity of bestatin. Eur J Pharm Sci 50: 420-428.
14. Juliano RL, Ling V,. 1976. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim Biophys Acta (BBA)-Biomembr 455: 152-162.
15. Medeiros B, Landau H, Morrow M, Lockerbie R, Pitts T, Eckhardt S,. 2007. The farnesyl transferase inhibitor, tipifarnib, is a potent inhibitor of the MDR1 gene product, P-glycoprotein, and demonstrates significant cytotoxic synergism against human leukemia cell lines. Leukemia 21: 739-746.
16. Nicolini G, Rigolio R, Miloso M, Bertelli AA, Tredici G,. 2001. Anti-apoptotic effect of trans-resveratrol on paclitaxel-induced apoptosis in the human neuroblastoma SH-SY5Y cell line. Neurosci Lett 302: 41-44.
17. Ruefli AA, Smyth MJ, Johnstone RW,. 2000. HMBA induces activation of a caspase-independent cell death pathway to overcome P-glycoprotein-mediated multidrug resistance. Blood 95: 2378-2385.
18. Sawafuji K, Miyakawa Y, Weisberg E, Griffin JD, Ikeda Y, Kizaki M,. 2003. Aminopeptidase inhibitors inhibit proliferation and induce apoptosis of K562 and STI571-resistant K562 cell lines through the MAPK and GSK-3beta pathways. Leuk Lymphoma 44: 1987-1996.
19. Smyth MJ, Krasovskis E, Sutton VR, Johnstone RW,. 1998. The drug efflux protein, P-glycoprotein, additionally protects drug-resistant tumor cells from multiple forms of caspase-dependent apoptosis. Proc Natl Acad Sci USA 95: 7024-7029.
20. Sui H, Pan SF, Feng Y, Jin BH, Liu X, Zhou LH, Hou FG, Wang WH, Fu XL, Han ZF, Ren JL, Shi XL, Zhu HR, Li Q,. 2014. Zuo Jin Wan reverses P-gp-mediated drug-resistance by inhibiting activation of the PI3K/Akt/NF-kappaB pathway. BMC Complement Altern Med 14: 279.
21. Tazzari PL, Cappellini A, Ricci F, Evangelisti C, Papa V, Grafone T, Martinelli G, Conte R, Cocco L, McCubrey JA, Martelli AM,. 2007. Multidrug resistance-associated protein 1 expression is under the control of the phosphoinositide 3 kinase/Akt signal transduction network in human acute myelogenous leukemia blasts. Leukemia 21: 427-438.
22. Umezawa H, Aoyagi T, Suda H, Hamada M, Takeuchi T,. 1976. Bestatin, an inhibitor of aminopeptidase B, produced by actinomycetes. J Antibiot 29: 97-99.
23. Vivanco I, Sawyers CL,. 2002. The phosphatidylinositol 3-kinase-AKT pathway in human cancer. Nat Rev Cancer 2: 489-501.
24. Wang L, Meng Q, Wang C, Liu Q, Peng J, Huo X, Sun H, Ma X, Liu K,. 2013. Dioscin restores the activity of the anticancer agent adriamycin in multidrug-resistant human leukemia K562/adriamycin cells by down-regulating MDR1 via a mechanism involving NF-κB signaling inhibition. J Nat Prod 76: 909-914.
25. Wang L, Wang C, Liu Q, Meng Q, Huo X, Sun P, Yang X, Sun H, Zhen Y, Peng J,. 2014. PEPT1-and OAT1/3-mediated drug-drug interactions between bestatin and cefixime in vivo and in vitro in rats, and in vitro in human. Eur J Pharm Sci 63: 77-86.
26. Whitlock NC, Baek SJ,. 2012. The anticancer effects of resveratrol: Modulation of transcription factors. Nutr Cancer 64: 493-502.
27. Xia Q, Wang Z-Y, Li H-Q, Diao Y-T, Li X-L, Cui J, Chen X-L, Li H,. 2012. Reversion of p-glycoprotein-mediated multidrug resistance in human leukemic cell line by diallyl trisulfide. Evidence-Based Complement Altern Med 2012: 719805.
28. Yao R, Cooper GM,. 1995. Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor. Science 267: 2003-2006.
29. Ye J, Zheng Y, Liu D,. 2009. [Reversal effect and its mechanism of ampelopsin on multidrug resistance in K562/ADR cells]. Zhongguo Zhong yao za zhi 34: 761-765.